2023 annual financial data
Unicycive Therapeutics 2023 Operating margin
Direct answer
Operating margin was -3,077.63%.
Operating income was -20,774,000 USD and net income was -30,544,000 USD.
Operating cash flow was -18,283,000 USD.
Get free Unicycive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 675,000 USD
- Operating income
- -20,774,000 USD
- Net income
- -30,544,000 USD
- Operating cash flow
- -18,283,000 USD